Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Cadbury Schweppes

7 Mar 2005 07:00

Embargoed Release: 07:00 hrs Monday 7th March 2005 SOPHEON PLC (`Sopheon' or `the Company') Product Innovation Focus Prompts Cadbury Schweppes to Deploy Sopheon Portfolio and Process Management System Food and Beverage Leader Implements Accolade Enterprise-wide to Support Integrated Portfolio Management, Increase Revenue from New Products Sopheon, the international software and services company, announced today thatCadbury Schweppes, a leading global confectionary and beverage company, hasselected Sopheon's Accolade portfolio and process management system to enhancea company-wide integrated portfolio management initiative aimed at increasinggrowth from innovation. The Accolade deployment spans 45 countries and includes2,400 users in product development, marketing and commercial strategy. Itencompasses all five of Cadbury's operating regions, specifically AmericasBeverages; Americas Confectionery; Europe, Middle East and Africa; EuropeanBeverages; and Asia Pacific.One of the largest international confectionery and beverage companies in theworld, Cadbury Schweppes employs well over 50,000 people and has an impressivelist of popular brand name products, including Cadbury, Schweppes, Halls,Trident, Dr Pepper, Snapple, Trebor and Dentyne. Sopheon's Accolade will beused both to support product portfolio management and to automate and managethe company's implementation of Stage-Gate, a widely-used product developmentprocess methodology. The software system will serve as a central repository forproduct information within business units and across the company. Accolade waschosen because of its ease-of-use, speed and ease of deployment, comprehensiveportfolio decision-support capabilities and overall cost-effectiveness."Cadbury Schweppes' stature as a leading innovator reaches back over 200years," said Christine Connelly, chief information officer at CadburySchweppes. "We are determined that this commitment to innovation will be asmuch a part of our future as it has been our past. To maintain ourmarket-leading position, we have outlined an organic growth strategy thatrelies upon our ability to innovate well and achieve high levels of return onour innovation investments. Sopheon's Accolade will give us the processuniformity and performance consistency we need to enable the sharing ofknowledge and expertise across a common process and system platform, ensuringfaster time-to-market with winning products.""The list of `most admired' companies adopting Sopheon's Accolade systemcontinues to grow," said Mike Connolly, Sopheon's director of sales in the U.K."Cadbury Schweppes is an industry vanguard with a clear vision of what it takesto drive innovation across geographies, organizational and functionalboundaries, and product categories to sustain business success. The company'sdecision to deploy Accolade reflects and affirms our solution's capacity tohandle the critical and unique product-portfolio and process-management needsof food and beverage manufacturers. We are delighted by the opportunity topartner with Cadbury Schweppes in the pursuit of its innovation and businessgoals."Sopheon Accolade‚® is a registered trademark of Sopheon plc.All other trademarks and registered trademarks are the soleproperty of their respective owners.About Cadbury SchweppesCadbury Schweppes (LSE: CBRY) is a major global group which manufactures,markets and distributes branded confectionery and beverage products around theworld. With origins stretching back over 200 years, today Cadbury Schweppes'products-which include brands such as Cadbury, Schweppes, Halls, Trident, DrPepper, Snapple, Trebor, Dentyne, Bubblicious and Bassett-are enjoyed in almostevery country around the world. In 2004, Cadbury Schweppes was voted Britain'smost admired company by its peers. It is number one in sugar and functionalconfectionery, a strong number two in gum and the world's third-largest softdrinks group. For more information, please visit www.cadburyschweppes.com.About SopheonSopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade‚® product development system automates gate- or phase-basedproduct development processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time-to-market. Sopheon's Monitor software operates as a "readingrobot" that automatically reviews, filters, analyzes and pushes relevantcontent to healthcare and engineering professionals to enable effectivecompliance with protocols, standards and regulations. Sopheon is listed on theAIM Market of the London Stock Exchange and on the Euronext in the Netherlands.For more information, please visit www.sopheon.com. # # # For further information contact:Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100 Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010END
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.